UNICREDIT BANK/CALL/BRISTOL-MYERS SQUIBB/85/0.1/18.06.25 | Market Closed - BOERSE MUENCHEN 15:40:32 2024-07-05 EDT | ||
| 0.005 EUR | +400.00% |
|
| 3 months | -83.33% | ||
| 6 months | -91.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.005 | +400.00% |
| 24-07-04 | 0.001 | -75.00% |
| 24-07-03 | 0.004 | -33.33% |
| 24-07-02 | 0.006 | -14.29% |
| 24-07-01 | 0.007 | +40.00% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 03:40 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC86KH |
| ISIN | DE000HC86KH9 |
| Date issued | 2023-07-24 |
| Strike | 85 $ |
| Maturity | 2025-06-18 (346 Days) |
| Parity | 10 : 1 |
| Emission price | 0.29 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.26 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
39.66
USD
Average target price
53.19
USD
Spread / Average Target
+34.13%
- Stock Market
- Warrants
- Warrant
